|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,024.00 JPY | +1.64% |
|
+10.36% | +11.95% |
| 05-18 | Bain Capital Earmarks Half of $10.5 Billion Asia Fund to Japan | MT |
| 05-14 | Bain-backed Tanabe Pharma targets three new drug launches a year in Japan | RE |
| Capitalization | 1,369B 8.62B 7.4B 6.77B 6.43B 11.84B 830B 12.05B 81.06B 31.42B 393B 32.33B 31.65B | P/E ratio 2026 |
104x | P/E ratio 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise value | 2,895B 18.22B 15.66B 14.33B 13.6B 25.05B 1,755B 25.48B 171B 66.45B 831B 68.39B 66.94B | EV / Sales 2026 |
0.7x | EV / Sales 2027 * | 0.65x |
| Free-Float |
92.77% | Yield 2026 |
3.56% | Yield 2027 * | 3.18% |
Last Transcript: Mitsubishi Chemical Group Corporation
Trading Mitsubishi Chemical Group Corporation
| 1 day | +1.69% | ||
| 1 week | +10.36% | ||
| Current month | +12.37% | ||
| 1 month | +6.49% | ||
| 3 months | -9.54% | ||
| 6 months | +23.81% | ||
| Current year | +11.95% |
| 1 week | 928.6 | 1,074.5 | |
| 1 month | 896.2 | 1,074.5 | |
| Current year | 846.4 | 1,171 | |
| 1 year | 727.8 | 1,171 | |
| 3 years | 594.1 | 1,171 | |
| 5 years | 594.1 | 1,171 | |
| 10 years | 437.3 | 1,319.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Manabu Chikumoto
CEO | Chief Executive Officer | - | 01/04/2024 |
Minoru Kida
DFI | Director of Finance/CFO | - | - |
Isao Yano
CMP | Compliance Officer | - | 25/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kiyomi Kikuchi
BRD | Director/Board Member | 63 | 01/06/2019 |
Tatsumi Yamada
BRD | Director/Board Member | 72 | 01/06/2020 |
Manabu Chikumoto
BRD | Director/Board Member | - | 25/06/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.64% | +10.36% | +38.48% | +26.98% | 8.7B | ||
| -0.13% | -7.14% | +52.70% | +63.42% | 83.14B | ||
| +0.63% | -0.94% | +22.03% | +11.60% | 53.4B | ||
| -1.19% | +0.90% | -6.17% | +13.64% | 15.57B | ||
| -0.12% | +1.93% | +70.99% | +77.34% | 14.77B | ||
| -0.78% | -3.09% | +1.03% | -20.03% | 10.3B | ||
| -1.74% | +2.63% | +219.64% | -4.78% | 8.66B | ||
| -1.84% | -5.69% | -9.56% | +8.69% | 8.31B | ||
| -1.59% | +6.17% | -3.53% | - | 7.46B | ||
| +0.71% | +16.11% | +78.47% | +42.65% | 6.49B | ||
| Average | -0.48% | +3.87% | +46.41% | +24.39% | 21.68B | |
| Weighted average by Cap. | -0.25% | -0.31% | +42.25% | +36.22% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 3,695B 23.26B 19.98B 18.28B 17.36B 31.97B 2,240B 32.51B 219B 84.81B 1,060B 87.28B 85.43B | 3,840B 24.17B 20.77B 19B 18.04B 33.23B 2,328B 33.79B 227B 88.14B 1,102B 90.71B 88.79B |
| Net income | 45.19B 284M 244M 224M 212M 391M 27.4B 398M 2.68B 1.04B 12.97B 1.07B 1.04B | 124B 778M 668M 612M 581M 1.07B 74.95B 1.09B 7.32B 2.84B 35.46B 2.92B 2.86B |
| Net Debt | 1,526B 9.61B 8.25B 7.55B 7.17B 13.21B 926B 13.43B 90.4B 35.03B 438B 36.06B 35.29B | 1,141B 7.18B 6.17B 5.65B 5.36B 9.87B 692B 10.04B 67.59B 26.19B 327B 26.96B 26.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/05/26 | 1,024.00 ¥ | +1.64% | 1,735,900 |
| 18/05/26 | 1,007.50 ¥ | -0.89% | 5,269,400 |
| 15/05/26 | 1,016.50 ¥ | -3.56% | 10,576,800 |
| 14/05/26 | 1,054.00 ¥ | +4.67% | 15,257,100 |
| 13/05/26 | 1,007.00 ¥ | +8.48% | 27,241,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4188 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















